Titrimetric determination of Cremophor® EL in aqueous solutions and biofluids: Part 2: Ruggedness of the method with respect to biofluids
- 31 December 1999
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 21 (5), 911-922
- https://doi.org/10.1016/s0731-7085(99)00212-5
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Cremophor Pharmacokinetics in Patients Receiving 3-, 6-, and 24-Hour Infusions of PaclitaxelJNCI Journal of the National Cancer Institute, 1996
- Determination of polyoxyethyleneglycerol triricinoleate 35 (Cremophor EL) in plasma by pre-column derivatization and reversed-phase high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1996
- Measurement of Cremophor EL Following Taxol: Plasma Levels Sufficient to Reverse Drug Exclusion Mediated by the Multidrug-Resistant PhenotypeJNCI Journal of the National Cancer Institute, 1993
- An in Vitro Model of Cyclosporine-Induced NephrotoxicityFundamental and Applied Toxicology, 1993
- Short-Term Effect of Various Doses of Cyclosporin A on Plasma Lipoproteins and its Distribution in Blood: An Experimental StudyHuman & Experimental Toxicology, 1993
- THE HEMODYNAMIC EFFECTS OF CREMOPHOR-ELTransplantation, 1991
- Cremophor EL, a widely used parenteral vehicle, is a potent inhibitor of protein kinase CBiochemical and Biophysical Research Communications, 1989
- Titrations of bivalent metal ions with sodium tetraphenylborate in the presence of polyethylene glycolThe Analyst, 1988
- Suspected anaphylactic reaction to Cremophor EL.BMJ, 1980
- Grenzflächenreaktionen zwischen kolloider Kieselsäure und Polyäthylenglykol sowie PolyäthylenglykolderivatenColloid and Polymer Science, 1970